Innovating Works

Gambro

Desconocido
DIREKT: Disarming the intravascular innate immune response to improve treatment modalities for chronic kidne... GAMBRO LUNDIA AB participó en un FP7: Chronic kidney disease is world wide a major cause of end-stage renal disease (ESRD). 800.000 patients in Europe and in the US, respectively...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.